Nyse jnj compare.

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9% ...View our stock quotes and sample our research offering. Explore Our Research Tools. Try our powerful stock tools to help compare investments and get ideas.Johnson & Johnson’s stock (NYSE: JNJ) has gained 27% since the March 23 lows, while Pfizer’s stock (NYSE: PFE) is up 16%, both underperforming the broader S&P, which is up 39%. The lockdown in ...New Brunswick, N.J. (January 25, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to …

6. Johnson & Johnson (NYSE:JNJ) Dividend Yield as of January 16: 2.61%. Johnson & Johnson (NYSE:JNJ) is a New Jersey-based pharmaceutical industry company that offers its DRIP policy to registered ...NYSE: JNJ. New Brunswick, New Jersey. $158.38 +3.72 (+2.40%) Share Price. as of December 1 4:00:00 PM EST. About Johnson & Johnson. Johnson & Johnson is a holding company, which engages in the ...

Get the latest Exxon Mobil Corp (XOM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

२०२३ मार्च ९ ... Johnson & Johnson(NYSE:JNJ): With the Fed anticipating higher ... compared to the negative 3.99% industry average. POWR Ratings Show Promise.NEW BRUNSWICK, N.J., December 22, 2022--Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it has completed its acquisition of ...Revenue Growth. Between 2017 and 2020, Merck’s revenues grew by about 13%, from around $42.3 billion to $48.0 billion, primarily led by its oncology drug – Keytruda – which saw its sales ...Oct 3, 2017 · Johnson & Johnson (NYSE:JNJ) is considered by many to be one of the best long-term stocks, due to its consistent high performance throughout many decades of both price and dividend growth. This is ...

For the full year, Johnson & Johnson (NYSE:JNJ) posted an EPS of $10.15, a 4% jump from the comparable period last year. As of the end of the third quarter of 2022, 85 hedge funds had stakes in ...

Johnson & Johnson (JNJ) key stats comparison: compare with other stocks by ... NYSE | $USD | Realtime. Summary · Ratings · Financials · Earnings · Dividends ...

What is the target price for Johnson & Johnson (JNJ)? A The latest price target for Johnson & Johnson ( NYSE : JNJ ) was reported by Cantor Fitzgerald on November 20, 2023 .While both Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) are good companies, ... Hard to compare with JNJ, because MDT is med tech and JNJ is med tech + pharma + consumer goods.Justin Sullivan/Getty Images News. Johnson & Johnson ( JNJ) said Thursday that it could launch an exchange offer for its stake in recently spun-out Kenvue ( NYSE: KVUE) "as early as the coming ...74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 158.38 +3.72 (+2.41%) At close: 04:00PM EST Oct 26, 2021 · JNJ is currently trading c.34% higher than the estimated price, hence is overvalued. That being said, JNJ is also known for beating analysts’ estimates. In the last 2 years, JNJ beat analysts ... Johnson & Johnson (JNJ). NYSE. Symbol. Exchange. Currency. JNJ, NYSE, USD, Real-time ... compared to the 3.7% reading seen in August. Overall, while the trend is.

Nov 30, 2023 · J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions. Johnson & Johnson's dividend of currently $1.19 per share and quarter represents an annualized dividend yield of 2.95%, which is quite attractive by historical standards. Taking into account the ...The average price target for Johnson & Johnson is $178.02. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $215.00 ,the lowest forecast is $165.00. The average price target represents 20.76% Increase from the current price of $147.42.The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential.Get the latest Kenvue Inc (KVUE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Johnson & Johnson (JNJ 0.32%) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity. J&J said that this move will unlock shareholder ...Kenvue went public at $22 per share, as the 173 million shares sold by Johnson grant it $3.8 billion in gross proceeds. The company holds about 1.72 billion shares in the company after the IPO and ...

Overview Stock Screener Earnings Calendar Sectors NYSE | JNJ U.S.: NYSE Johnson & Johnson Watch list Set a price target alert After Hours Last Updated: Nov 29, 2023 7:16 …Dec 1, 2023 · JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion.

Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Johnson & Johnson : Historical stock chart comparison, Stock Johnson & Johnson | JNJ | US4781601046 | Nyse.Feb 14, 2023 · NYSE: JNJ Johnson & Johnson. Market Cap. $372B. Today's Change (0.74%) $1.14. ... Johnson & Johnson (JNJ 0.74%) and AbbVie (ABBV 0.35%) are two of the bigger names in healthcare stocks. The ... Galeanu Mihai/iStock via Getty Images. Thesis. I first wrote about AbbVie Inc. (NYSE:ABBV) back in Aug 2021.At that time, the stock was trading at $114 per share, or only about 8x times its ...NYSE: JNJ Johnson & Johnson. Market Cap. $381B. Today's Change (2.40%) $3.72. Current Price. $158.38. ... Although it can be useful when comparing two similar companies, market capitalization and ...We believe Johnson & Johnson stock (NYSE: JNJ) is currently a better pick than Eli Lilly stock (NYSE: LLY), given its better prospects. Although Eli Lilly LLY -0.4% is trading at a comparatively ...Johnson & Johnson Price Performance. JNJ stock opened at $158.38 on Friday. The stock has a market capitalization of $381.27 billion, a PE ratio of 11.76, a price-to-earnings-growth ratio of 3.20 and a beta of 0.57. The company’s 50-day moving average is $152.74 and its 200-day moving average is $159.77. The company has a debt-to …

Dec 5, 2022 · We believe Johnson & Johnson stock (NYSE: JNJ) is currently a better pick than Eli Lilly stock (NYSE: LLY), given its better prospects. Although Eli Lilly LLY -0.4% is trading at a comparatively ...

Its Peers: A Comparison - News Heater. Johnson & Johnson (JNJ) vs. Its Peers: A Comparison. Johnson & Johnson (NYSE: JNJ) has a price-to-earnings ratio of 30.23x that is above its average ratio. Additionally, the 36-month beta value for JNJ is 0.57. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 2 rating it as ...

We compare a slew of factors, such as historical revenue growth, returns, and valuation using P/S as a base, in an interactive dashboard analysis of Coca-Cola vs. …Reports Q4 and Full-Year 2022 Results. 2022 Fourth-Quarter reported sales decline of 4.4% to $23.7 Billion primarily driven by unfavorable foreign exchange and reduced COVID-19 Vaccine sales vs. prior year. Operational growth excluding COVID-19 Vaccine of 4.6%*. 2022 Full-Year reported sales growth of 1.3% to $94.9 Billion primarily driven by ...Discover historical prices for JNJ stock on Yahoo Finance. View daily, weekly or monthly format back to when Johnson & Johnson stock was issued. ... Johnson & Johnson (JNJ) NYSE - NYSE Delayed ...42.65. 33.08. Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison. The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the …10 Wall Street research analysts have issued 12 month price targets for Duke Energy's stock. Their DUK share price targets range from $91.00 to $110.00. On average, they expect the company's stock price to reach $98.55 in the next year. This suggests a possible upside of 6.4% from the stock's current price.NYSE: JNJ. New Brunswick, New Jersey. $158.38 +3.72 (+2.40%) Share Price. as of December 1 4:00:00 PM EST. About Johnson & Johnson. Johnson & Johnson is a holding company, which engages in the ...The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the …Johnson & Johnson and Novavax have both surpassed that. They've reported 66% and 89.3% overall efficacy, respectively. And both have shown positive safety data. But the key to success in this ...Johnson & Johnson is currently listed on NYSE under JNJ. One share of JNJ stock can currently be purchased for approximately $159.33. Is Johnson & Johnson (JNJ) ...NYSE: JNJ Johnson & Johnson. Market Cap. $381B. Today's Change (2.40%) $3.72. Current Price. $158.38. ... Although it can be useful when comparing two similar companies, market capitalization and ...Johnson & Johnson (NYSE:JNJ) has declared $1.19/share quarterly dividend, in line with previous.Payable Sept. 7; for shareholders of record Aug.

Justin Sullivan/Getty Images News. Johnson & Johnson ( JNJ) said Thursday that it could launch an exchange offer for its stake in recently spun-out Kenvue ( NYSE: KVUE) "as early as the coming ...Fiscal Q3 2023 ended 10/1/23. Reported on 10/17/23. Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more...After an 11.22% decline in its share price over the past year, the average JNJ price target of $176.38 per share implies 14.16% upside potential. Disclosure. …Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several ...Instagram:https://instagram. nxst tickercollectible quarter coinsngrb stocksmall real estate investment Broadens MedTech Portfolio with World Leading Solutions for Heart Recovery Strengthens Position in High-Growth MedTech Segments. NEW BRUNSWICK, N.J. – December 22, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it has completed its …Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... NYSE:JNJ US$381.3b. Price History & Performance. Summary of all time highs, changes and price drops for Pfizer; Historical stock prices; Current Share Price: US$28.91: 52 Week High: sgov dividendbaker moving insurance Potentially undervalued companies in the Pharmaceuticals & Biotech industry. Research Johnson & Johnson's (NYSE:JNJ) stock key valuation metrics while comparing it with … parnassus core equity fund Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.NYSE:JNJ is not an exception to the falling share prices due to the macro-economic environment. Despite this company’s Q3 results beating the wall street estimates, the stock price keeps falling. We are expecting a rebound soon as confirmed by the Nedium indicator.